Wolden is an employee and shareholder of Novo Nordisk A/S
Much like Wegovy and Zepbound, Amgen's treatment activates a gut hormone receptor called GLP-1 to help regulate a person's appetite
Improves Related Risk Factors GLP-1s have also been shown to reduce the severity of sleep apnea a condition strongly linked to faster cognitive decline and Alzheimers progression
For example: one peptide may support tissue repair another peptide may support inflammation balance another peptide may support recovery signaling Combination approaches are typically individualized based on specific recovery goals and medical guidance
Cahuzac KM, Lubin A, Bosch K, Stokes N, Shoenfeld SM, Zhou R, Lemon H, Asara J, Parsons RE
A 2023 study in Microorganisms found that multiple isolates suppressed subcutaneous fat formation, with two strains substantially reducing weight gain